Christine Bailes
Family · Wasilla, AKNPI 1841686201
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,229 and has fallen 96.3% since, to $45 in 2024.
Across 103 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$451
- AbbVie$310
- Neurocrine Biosciences, Inc.$276
- Sunovion Pharmaceuticals Inc.$151
- ADMA Biomanufacturing LLC$111
- Neurelis, Inc.$106
- plus $790 from 22 others
What the payments were for
- Consulting fees$1507%
- Food & beverage$2,03393%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 17 | $451 |
| AbbVie(2 entities) | 12 | $310 |
| Neurocrine Biosciences, Inc. | 16 | $276 |
| Sunovion Pharmaceuticals Inc. | 7 | $151 |
| ADMA Biomanufacturing LLC | 1 | $111 |
| Neurelis, Inc. | 6 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Amgen(2 entities) | 4 | $86 |
| Bristol Myers Squibb | 3 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $53 |
| SK Life Science, Inc. | 2 | $42 |
| Pfizer | 2 | $37 |
| Tanabe Pharma America, Inc. | 2 | $36 |
| AstraZeneca | 2 | $36 |
| Lundbeck LLC | 2 | $36 |
| UCB, Inc. | 2 | $35 |
| EMD Serono, Inc. | 2 | $32 |
| GSK | 2 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Zogenix Inc. | 2 | $28 |
| Sanofi | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| TG Therapeutics, Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Medtronic | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYSABRI$150
How this compares
$2,196 in reported general payments places this provider in the 85th percentile of 315 family providers in Alaska.
Other family in Wasilla
- Kymberli BrockWasilla$5K
- Sarah NielsenWasilla$4K
- Alison ArmourWasilla$4K
- Stephanie McQuillinWasilla$4K
- Liudmila FedorWasilla$4K
- Debby MaloneyWasilla$3K
- Alysa SonnentagWasilla$3K
- Lisa Bouyea-FranciesWasilla$2K
- Kathleen MatthewsWasilla$2K
- Erica MuchaWasilla$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.